Xiaohua Sun

Title: Innovations by Xiaohua Sun in Pharmaceutical Technology

Introduction

Xiaohua Sun is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of crystalline forms of compounds. His work focuses on enhancing the stability and efficacy of pharmaceutical compositions.

Latest Patents

Xiaohua Sun holds a patent for a "Crystalline form of compound, method for preparing the same, pharmaceutical composition and use." This patent relates to three crystalline forms of the compound 6-[[4-[2-fluoro-4-[[1-[(4-fluorophenyl)aminoformyl]cyclopropanecarbonyl]-amino]phenoxy]-6-methoxy-7-quinolyl]oxy]hexanoic acid. These forms are designed for the treatment of diseases associated with protein kinases AXL and/or VEGFR2. The patent outlines methods for preparing these crystalline forms, which exhibit good chemical stability and high product yield and purity, facilitating stable and mass production.

Career Highlights

Xiaohua Sun is currently employed at Beijing Konruns Pharmaceutical Co., Ltd. His work at this company has allowed him to focus on innovative pharmaceutical solutions that can be effectively produced and utilized in medical applications.

Collaborations

Xiaohua has collaborated with notable colleagues, including Long Wang and Hongzhen Yang, who contribute to the research and development efforts in his field.

Conclusion

Xiaohua Sun's contributions to pharmaceutical technology through his innovative patents demonstrate his commitment to advancing medical science. His work not only enhances the stability of pharmaceutical compounds but also paves the way for effective treatments for various diseases.